Open AccessEffect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
Author(s) -
Richard P. Ramonell,
Imran H. Iftikhar
Publication year - 2020
Publication title -
lung
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 57
eISSN - 1432-1750
pISSN - 0341-2040
DOI - 10.1007/s00408-019-00310-8
Subject(s) - mepolizumab , benralizumab , medicine , asthma , dupilumab , exacerbation , meta analysis , placebo , population , immunology , eosinophil , pathology , alternative medicine , environmental health
Several new treatments for severe asthma have become available in the last decade; yet, little data exist to guide their use in specific patient populations.